Home » Topics » BioWorld Science

BioWorld Science
RSS

Neutralase to enter phase II

April 12, 1996

YM-087 in phase I for CHF

April 12, 1996

New angiotensin II antagonists from Kotobuki

April 12, 1996

Sanofi Winthrop claims elastase inhibitors

April 12, 1996

Zafirlukast approval recommended

April 12, 1996

BDNF, CNTF protect against metabolic stress in vitro

April 12, 1996

New antiasthma drugs from the SmithKline Beecham Laboratory

April 12, 1996

Lubeluzole + DCLHb potentially effective in stroke

April 12, 1996

Hu23F2G advances to phase II

April 12, 1996

Neuronal cell protectant isolated from natural source

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...